Blockade of nociceptive sensory afferent activity of the rat knee joint by the bradykinin B2 receptor antagonist fasitibant

Osteoarthritis and Cartilage

Volumn 21, Issue 9, 2013, Pages 1346-1354

  Gomis, A ^b   Meini, S ^a   Miralles, A ^b   Valenti, C ^a   Giuliani, S ^a   Belmonte, C ^b   Maggi, C A ^a  

^a Menarini Ricerche SpA   (Italy)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Animal models; Bradykinin; Inflammation; Nociceptors; Pain

Indexed keywords

BRADYKININ B2 RECEPTOR ANTAGONIST; CARRAGEENAN; FASITIBANT; MEN 16132; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; JOINT FUNCTION; KNEE; KNEE OSTEOARTHRITIS; MALE; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE;

ANIMAL MODELS; BRADYKININ; INFLAMMATION; NOCICEPTORS; PAIN;

ACTION POTENTIALS; ANIMALS; ARTHRALGIA; ARTHRITIS, EXPERIMENTAL; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MALE; NEURONS, AFFERENT; NOCICEPTORS; ORNITHINE; OSTEOARTHRITIS, KNEE; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; SULFONAMIDES; TREATMENT OUTCOME;

EID: 84882733403     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.03.013     Document Type: Article

References (44)

1. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992, 44:1-80.
2. Couture R., Harrisson M., Vianna R.M., Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol 2001, 429:161-176.
3. Meini S., Maggi C.A. Knee osteoarthritis: a role for bradykinin?. Inflamm Res 2008, 57:351-361.
4. Leeb-Lundberg L.M., Marceau F., Muller-Esterl W., Pettibone D.J., Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005, 57:27-77.
5. Cesare P., McNaughton P. Anovel heat-activated current in nociceptive neurons and its sensitization by bradykinin. Proc Natl Acad Sci USA 1996, 93:15435-15439.
6. Dray A., Perkins M. Bradykinin and inflammatory pain. Trends Neurosci 1993, 16:99-104.
7. Chuang H.H., Prescott E.D., Kong H., Shields S., Jordt S.E., Basbaum A.I., et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001, 411:957-962.
8. Fan H.C., Zhang X., McNaughton P.A. Activation of the TRPV4 ion channel is enhanced by phosphorylation. JBiol Chem 2009, 284:27884-27891.
9. Bandell M., Story G.M., Hwang S.W., Viswanath V., Eid S.R., Petrus M.J., et al. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004, 41:849-857.
10. Liu B., Linley J.E., Du X., Zhang X., Ooi L., Zhang H., et al. The acute nociceptive signals induced by bradykinin in rat sensory neurons are mediated by inhibition of M-type K+ channels and activation of Ca2+-activated Cl-channels. JClin Invest 2010, 120:1240-1252.
11. Goldring M.B., Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol 2011, 23:471-478.
12. Scanzello C.R., Goldring S.R. The role of synovitis in osteoarthritis pathogenesis. Bone 2012, 51:249-257.
13. Ashraf S., Mapp P.I., Walsh D.A. Angiogenesis and the persistence of inflammation in a rat model of proliferative synovitis. Arthritis Rheum 2010, 62:1890-1898.
14. Lee M.J., Han K.J., Kwon H.J., Jung H.S., Cho S.W. Effects of hyaluronan on carrageenan-induced synovitis in rat TMJ. Anat Cell Biol 2010, 43:125-131.
15. Kumakura S., Kamo I., Tsurufuji S. Role of bradykinin in the vascular permeability response induced by carrageenan in rats. Br J Pharmacol 1988, 93:739-746.
16. Ferreira S.H., Lorenzetti B.B., Poole S. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol 1993, 110:1227-1231.
17. 9] BK in carrageenan-induced edema. Peptides 1996, 17:1009-1015.
18. Tonussi C.R., Ferreira S.H. Tumour necrosis factor-alpha mediates carrageenan-induced knee-joint incapacitation and also triggers overt nociception in previously inflamed rat knee-joints. Pain 1999, 82:81-87.
19. 2 and neurokinin-1 receptor activation on endothelial cell proliferation in acute synovitis. FASEB J 2004, 18:762-764.
20. 2 receptor on nociception in rats and mice. Pain 1997, 71:89-97.
21. Gomis A., Pawlak M., Balazs E.A., Schmidt R.F., Belmonte C. Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthritis Rheum 2004, 50:314-326.
22. Gomis A., Miralles A., Schmidt R.F., Belmonte C. Nociceptive nerve activity in an experimental model of knee joint osteoarthritis of the guinea pig: effect of intra-articular hyaluronan application. Pain 2007, 130:126-136.
23. Pawlak M., Borkiewicz P., Podgórski T., Schmidt R.F. The activity of fine afferent nerve fibers of the rat knee joint and their modulation by inflammatory mediators. Ortop Traumatol Rehabil 2008, 10:63-74.
24. Song I., Althoff C.E., Hermann K., Scheel A.K., Knetsch T., Burmester G., et al. Contrast-enhanced ultrasound in monitoring the efficacy of a bradykinin receptor-2 antagonist in painful knee osteoarthritis compared to magnetic resonance imaging. Ann Rheum Dis 2009, 68:75-83.
25. 2 receptor. Invitro pharmacology and molecular characterization. Eur J Pharmacol 2005, 528:7-16.
26. 2 receptor antagonist MEN16132 in rat invitro bioassays. Eur J Pharmacol 2009, 615:10-16.
27. 2 receptor antagonism in rat and human articular chondrocytes. Br J Pharmacol 2011, 162:611-622.
28. 2 receptor antagonism in human synovial fibroblasts. Br J Pharmacol 2009, 158:1996-2004.
29. 2 receptor antagonist: invivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs. JPharmacol Exp Ther 2005, 315:616-623.
30. 2 receptor antagonist, prevents the endogenous bradykinin effects in guinea-pig airways. Eur J Pharmacol 2008, 579:350-356.
31. 2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats. JPharmacol Exp Ther 2009, 331:1025-1032.
32. 2 receptor antagonist, and dexamethasone in carrageenan-induced knee joint arthritis in rats. Br J Pharmacol 2010, 161:1616-1627.
33. 2 receptor antagonist, and dexamethasone interact to inhibit carrageenan-induced inflammatory arthritis in rats. Br J Pharmacol 2012, 166:1403-1410.
34. Felson D.T. The sources of pain in knee osteoarthritis. Curr Opin Rheumatol 2005, 17:624-628.
35. Just S., Pawlak M., Heppelmann B. Responses of fine primary afferent nerve fibres innervating the rat knee joint to defined torque. JNeurosci Methods 2000, 103:157-162.
36. Schaible H.G., Schmidt R.F. Activation of groups III and IV sensory units in medial articular nerve by local mechanical stimulation of knee joint. JNeurophysiol 1983, 49:35-44.
37. Kaufman G.N., Zaouter C., Valteau B., Sirois P., Moldovan F. Nociceptive tolerance is improved by bradykinin receptor B1 antagonism and joint morphology is protected by both endothelin type A and bradykinin receptor B1 antagonism in a surgical model of osteoarthritis. Arthritis Res Ther 2011, 13. R76.
38. Heppelmann B., Pawlak M. Inhibitory effect of somatostatin on the mechanosensitivity of articular afferents in normal and inflamed knee joints of the rat. Pain 1997, 73:377-382.
39. Birrell G.J., McQueen D.S., Iggo A., Grubb B.D. Prostanoid-induced potentiation of the excitatory and sensitizing effects of bradykinin on articular mechanonociceptors in the rat ankle joint. Neuroscience 1993, 54:537-544.
40. 2 in the sensitization of mechanoreceptors in normal and inflamed ankle joints of the rat. Exp Brain Res 1991, 84:383-392.
41. 2 receptor-dependent mechanism. JNeurophysiol 2010, 103:155-163.
42. 2 receptor. Br J Pharmacol 2011, 162:1202-1212.
43. Vauquelin G., Charlton S.J. Long-lasting target binding and rebinding as mechanisms to prolong invivo drug action. Br J Pharmacol 2010, 161:488-508.
44. Broadley K.J., Blair A.E., Kidd E.J., Bugert J.J., Ford W.R. Bradykinin-induced lung inflammation and bronchoconstriction: role in PIV-3 induced inflammation and airways hyperreactivity. JPharmacol Exp Ther 2010, 335:681-692.